MUC3A (mucin 3A, cell surface associated)

2003-02-01  

Identity

HGNC
LOCATION
7q22.1
LOCUSID
ALIAS
MUC-3A,MUC3
FUSION GENES

Other Information

Locus ID:

NCBI: 4584
MIM: 158371
HGNC: 7513
Ensembl: ENSG00000169894

Variants:

dbSNP: 4584
ClinVar: 4584
TCGA: ENSG00000169894
COSMIC: MUC3A

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000169894ENST00000379458Q02505
ENSG00000169894ENST00000414964A0A182DWF7
ENSG00000169894ENST00000483366Q02505

Expression (GTEx)

0
5
10
15
20
25
30
35
40
45
50

Pathways

PathwaySourceExternal ID
Metabolism of proteinsREACTOMER-HSA-392499
Post-translational protein modificationREACTOMER-HSA-597592
O-linked glycosylationREACTOMER-HSA-5173105
O-linked glycosylation of mucinsREACTOMER-HSA-913709
Termination of O-glycan biosynthesisREACTOMER-HSA-977068
DiseaseREACTOMER-HSA-1643685
Diseases of glycosylationREACTOMER-HSA-3781865
Immune SystemREACTOMER-HSA-168256
Innate Immune SystemREACTOMER-HSA-168249
C-type lectin receptors (CLRs)REACTOMER-HSA-5621481
Dectin-2 familyREACTOMER-HSA-5621480
Diseases associated with O-glycosylation of proteinsREACTOMER-HSA-3906995
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)REACTOMER-HSA-5083632
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)REACTOMER-HSA-5083625
Defective GALNT12 causes colorectal cancer 1 (CRCS1)REACTOMER-HSA-5083636

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
380695092023Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy.0
380695092023Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy.0
356551612022MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway.6
356551612022MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway.6
332494002021KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.14
339948522021MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer.8
343266912021MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity.5
332494002021KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.14
339948522021MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer.8
343266912021MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity.5
302600462019MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma.23
302600462019MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma.23
273741812016Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma.14
273741812016Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma.14
205108742010Promoter hypomethylation contributes to the expression of MUC3A in cancer cells.13

Citation

Dessen P

MUC3A (mucin 3A, cell surface associated)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/41458